MannKind Corporation (MNKD): Price and Financial Metrics
MNKD Price/Volume Stats
Current price | $4.06 | 52-week high | $5.75 |
Prev. close | $4.10 | 52-week low | $2.91 |
Day low | $4.02 | Volume | 504,842 |
Day high | $4.12 | Avg. volume | 3,013,560 |
50-day MA | $4.58 | Dividend yield | N/A |
200-day MA | $4.54 | Market Cap | 1.09B |
MNKD Stock Price Chart Interactive Chart >
MNKD POWR Grades
- MNKD scores best on the Growth dimension, with a Growth rank ahead of 96.65% of US stocks.
- The strongest trend for MNKD is in Value, which has been heading up over the past 177 days.
- MNKD ranks lowest in Stability; there it ranks in the 10th percentile.
MNKD Stock Summary
- MANNKIND CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 6.05% of US listed stocks.
- MNKD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 5.64% of US stocks.
- As for revenue growth, note that MNKD's revenue has grown 140.99% over the past 12 months; that beats the revenue growth of 95.96% of US companies in our set.
- Stocks that are quantitatively similar to MNKD, based on their financial statements, market capitalization, and price volatility, are VAPO, APPS, OTRK, BYND, and SONX.
- MNKD's SEC filings can be seen here. And to visit MANNKIND CORP's official web site, go to www.mannkindcorp.com.
MNKD Valuation Summary
- MNKD's price/sales ratio is 6.9; this is 263.16% higher than that of the median Healthcare stock.
- MNKD's price/sales ratio has moved NA NA over the prior 233 months.
Below are key valuation metrics over time for MNKD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
MNKD | 2023-09-22 | 6.9 | -4.2 | -23.0 | -62.1 |
MNKD | 2023-09-21 | 7.0 | -4.2 | -23.2 | -62.7 |
MNKD | 2023-09-20 | 7.0 | -4.3 | -23.5 | -63.1 |
MNKD | 2023-09-19 | 7.2 | -4.4 | -24.0 | -64.2 |
MNKD | 2023-09-18 | 7.4 | -4.5 | -24.6 | -65.4 |
MNKD | 2023-09-15 | 7.4 | -4.5 | -24.6 | -65.5 |
MNKD Growth Metrics
- Its 2 year net income to common stockholders growth rate is now at -102.86%.
- Its 3 year cash and equivalents growth rate is now at 91.81%.
- Its year over year price growth rate is now at -23.63%.

The table below shows MNKD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 76.226 | -90.65 | -97.514 |
2022-06-30 | 65.612 | -77.761 | -87.508 |
2022-03-31 | 69.998 | -67.226 | -94.008 |
2021-12-31 | 75.442 | -61.709 | -80.926 |
2021-09-30 | 81.37 | -49.127 | -79.276 |
2021-06-30 | 74.511 | -47.403 | -86.105 |
MNKD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MNKD has a Quality Grade of C, ranking ahead of 42.97% of graded US stocks.
- MNKD's asset turnover comes in at 0.384 -- ranking 124th of 680 Pharmaceutical Products stocks.
- VERU, PLX, and LGND are the stocks whose asset turnover ratios are most correlated with MNKD.
The table below shows MNKD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.384 | 0.611 | -0.321 |
2021-03-31 | 0.424 | 0.627 | -0.330 |
2020-12-31 | 0.673 | 0.622 | -0.564 |
2020-09-30 | 0.673 | 0.595 | -0.391 |
2020-06-30 | 0.666 | 0.529 | -0.297 |
2020-03-31 | 0.705 | 0.516 | -0.324 |
MNKD Price Target
For more insight on analysts targets of MNKD, see our MNKD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $6.17 | Average Broker Recommendation | 1.33 (Strong Buy) |
MannKind Corporation (MNKD) Company Bio
MannKind Corporation focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States. The company was founded in 1991 and is based in Valencia, California.
Latest MNKD News From Around the Web
Below are the latest news stories about MANNKIND CORP that investors may wish to consider to help them evaluate MNKD as an investment opportunity.
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue GrowthPharma stocks can be a great investment, particularly if they have solid performance, revenue growth and a positive outlook. |
MannKind Corporation Announces Participation at Upcoming ConferencesWESTLAKE VILLAGE, Calif. and DANBURY, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it will be participating at upcoming conferences. H.C. Wainwright 25th Annual Global Investment Conference – Monday, September 11, 2023 at 8:30 am (ET) Morgan Stanley 21st Annual Global Healthcare Conferen |
12 Best High Risk Penny Stocks to Buy NowIn this article, we will take a look at the 12 best high risk penny stocks to buy now. To see more such companies, go directly to 5 Best High Risk Penny Stocks to Buy Now. Investors are jubilant over Nvidia crushing analyst estimates in its latest quarterly report. Analysts are increasing their price targets […] |
When Will MannKind Corporation (NASDAQ:MNKD) Breakeven?We feel now is a pretty good time to analyse MannKind Corporation's ( NASDAQ:MNKD ) business as it appears the company... |
3 Biotech Stocks to Sell in August Before They Crash and BurnThese biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late. |
MNKD Price Returns
1-mo | -13.06% |
3-mo | -0.25% |
6-mo | -0.98% |
1-year | 27.67% |
3-year | 110.36% |
5-year | 121.86% |
YTD | -22.96% |
2022 | 20.59% |
2021 | 39.62% |
2020 | 142.64% |
2019 | 21.70% |
2018 | -54.31% |
Continue Researching MNKD
Want to do more research on Mannkind Corp's stock and its price? Try the links below:Mannkind Corp (MNKD) Stock Price | Nasdaq
Mannkind Corp (MNKD) Stock Quote, History and News - Yahoo Finance
Mannkind Corp (MNKD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...